Biochemical assays and deep cyclic inhibition in cancer treatment
Drug Target Review
JULY 12, 2023
Molecular-level biochemical assays like transcriptomics, genomics and proteomics have emerged as valuable tools for identifying potential targets in cancer treatment through deep cyclic inhibition (DCI). Our assays and bioinformatics modelling can help identify certain indications that are appropriate for DCI while ruling others out.
98 
Let's personalize your content